Hypoestenone - Compound Card

Hypoestenone

Select a section from the left sidebar

Hypoestenone

Structure
Zoomed Structure
  • Family: Plantae - Acanthaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Fusicoccane Diterpene Ketone
Canonical Smiles CC([C@@H]1CC(=O)[C@@]2([C@@H]1CC=C(C)[C@H]1C(=C(C)C(=O)C1)C2)C)C
InChI InChI=1S/C20H28O2/c1-11(2)14-9-19(22)20(5)10-16-13(4)18(21)8-15(16)12(3)6-7-17(14)20/h6,11,14-15,17H,7-10H2,1-5H3/t14-,15-,17+,20-/m0/s1
InChIKey RQBPREVSQRPKAH-COCVIAQXSA-N
Formula C20H28O2
HBA 2
HBD 0
MW 300.44
Rotatable Bonds 1
TPSA 34.14
LogP 4.5
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 22
Formal Charge 0
Fraction CSP3 0.7
Exact Mass 300.21
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Hypoestes foskalii Acanthaceae Plantae 13570

Showing of synonyms

  • Al Musayeib NM, Mothana RA, et al. (2014). Hypoestenonols A and B, new fusicoccane diterpenes from Hypoestes forskalei. Phytochemistry Letters,2014,10,23-27. [View]
Pubchem: 10424900
Bindingdb: 50532223

No compound-protein relationship available.

Structure

SMILES: C1C(=O)CC(C=12)C=CCC3C(C2)C(=O)CC3

Level: 0

Mol. Weight: 300.44 g/mol

Anti-plasmodial

Absorption

Caco-2 (logPapp)
-4.55
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.66
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.57

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.43
Plasma Protein Binding
69.27
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
13.31
Organic Cation Transporter 2
Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.93
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.06
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
5.62
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
0.5
Rat (Acute)
1.92
Rat (Chronic Oral)
1.71
Fathead Minnow
4.11
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
378.58
Hydration Free Energy
-4.46
Log(D) at pH=7.4
3.19
Log(P)
4.66
Log S
-4.38
Log(Vapor Pressure)
-5.44
Melting Point
125.89
pKa Acid
8.73
pKa Basic
3.69

No predicted protein targets found for this compound.

Download SDF